natgillin/translations-raw huggingface dataset:
The recommended dose of enoxaparin sodium is a single intravenous injection of 30 mg and additionally, immediately after the intravenous injection, a 1 mg/kg subcutaneous dose, followed by 1 mg/kg administered subcutaneously every 12 hours (maximum 100 mg for each of the first two doses only, followed by 1 mg/kg bw subcutaneously).
Priporočeni odmerek je enkratna intravenska injekcija 30 mg natrijevega enoksaparinata, ki ji takoj sledi subkutani odmerek 1 mg/kg in nato subkutani odmerek 1 mg/kg vsakih 12 ur (največ 100 mg za vsakega od prvih dveh subkutanih odmerkaov, čemur sledi subkutani odmerek 1 mg/kg TM).
The recommended dose of enoxaparin sodium is a single intravenous injection of 30 mg and additionally, immediately after the intravenous injection, a 1 mg/kg subcutaneous dose, followed by 1 mg/kg administered subcutaneously every 12 hours (maximum 100 mg for each of the first two doses only, followed by 1 mg/kg bw subcutaneously).
Priporočeni odmerek je enkratna intravenska injekcija 30 mg natrijevega enoksaparinata, ki ji takoj sledi subkutani odmerek 1 mg/kg in nato subkutani odmerek 1 mg/kg vsakih 12 ur (največ 100 mg za vsakega od prvih dveh subkutanih odmerkov, čemur sledi subkutani odmerek 1 mg/kg TM).
The recommended dose of enoxaparin sodium, equivalent to 1 mg/kg bw introduced into the arterial line at the beginning of a dialysis session is usually sufficient for a 4 hour session.
Priporočeni odmerek natrijevega enoksaparinata, ki ustreza 1 mg/kg TM, apliciran v arterijsko linijo na začetku dialize, običajno zadošča za 4-urno dializo.
The recommended dose of enoxaparin sodium, equivalent to 1 mg/kg bw introduced into the arterial line at the beginning of a dialysis session is usually sufficient for a 4 hour session.
Priporočeni odmerek natrijevega enoksaparinata, ki ustreza 1 mg/kg TM, apliciran v arterijsko linijo na začetku dialize, ponavadi zadošča za 4-urno dializo.
The recommended dose of Epivir is 300 mg daily.
Priporočen dnevni odmerek zdravila Epivir je 300 mg.
The recommended dose of Extavia is 250 microgram (8.0 million IU), contained in 1 ml of the reconstituted solution (see section 6.6), to be injected subcutaneously every other day.
Priporočeni odmerek zdravila Extavia je 250 mikrogramov (8,0 milijonov i.e.), kolikor ga vsebuje 1 ml pripravljene raztopine (glejte poglavje 6.6), ki ga je treba injicirati subkutano vsak drugi dan.
The recommended dose of Fabrazyme for children and adolescents 8 – 16 years is 1 mg/kg body weight, once every 2 weeks.
Priporočeni odmerek zdravila Fabrazyme za otroke in mladostnike od 8 do 16 let je 1 mg/kg telesne mase, enkrat na vsaka 2 tedna.
The recommended dose of Faslodex is 500 mg given once a month, with an additional 500-mg dose given two weeks after the first dose.
Priporočeni odmerek zdravila Faslodex je 500 mg enkrat na mesec, z dodatnim 500-miligramskim odmerkom dva tedna po prvem odmerku.
The recommended dose of filgrastim for PBPC mobilisation after myelosuppressive chemotherapy is
Priporočeni odmerek filgrastima za izplavljanje matičnih celic v periferno kri po mielosupresivni kemoterapiji je 0,5 M e./kg/dan (5 µg/kg/dan).
The recommended dose of filgrastim for PBPC mobilisation after myelosuppressive chemotherapy is
Priporočeni odmerek filgrastima za izplavljanje PBPC po mielosupresivni kemoterapiji je 0,5 M e./kg/dan (5 mikrogramov/kg/dan).
The recommended dose of filgrastim for PBPC mobilisation after myelosuppressive chemotherapy is
Priporočeni odmerek filgrastima za izplavljanje po mielosupresivni kemoterapiji je 0,5 M e./kg/dan (5 mikrogramov/kg/dan).
The recommended dose of filgrastim for PBPC mobilisation when used alone is 1.0 MU/kg/day (10 micrograms/kg/day) for 5-7 consecutive days.
Če se filgrastim uporablja samostojno, je priporočeni odmerek za izplavljanje PBPC 1,0 M e./kg/dan (10 mikrogramov/kg/dan) 5-7 zaporednih dni.
The recommended dose of filgrastim is 0.5 MIU (5 μg)/kg/day.
Priporočen odmerek filgrastima je 0,5 x 106i.e. (5 μg)/kg/dan.
The recommended dose of filgrastim is 0.5 MU (5 micrograms)/kg/day.
Priporočeni odmerek filgrastima je 0,5 M e. (5 mikrogramov)/kg/dan.
The recommended dose of Firazyr is one injection (3 ml, 30 mg) applied subcutaneously (under the skin) as soon as you notice the attack of hereditary angioedema (for example increased skin swelling, particularly affecting the face and neck, or increasing tummy pain).
Priporočeni odmerek zdravila Firazyr je ena injekcija (3 ml, 30 mg), dana subkutano (pod kožo), kakor hitro opazite napad hereditarnega (prirojenega) angioedema (na primer povečano otekanje kože, zlasti na obrazu in vratu, ali močnejše bolečine v trebuhu)
The recommended dose of Firazyr is one injection.
Priporočeni odmerek zdravila Firazyr je ena injekcija.
The recommended dose of fondaparinux is 2.5 mg once daily administered post-operatively by subcutaneous injection.
Priporočeni odmerek fondaparinuksa je 2,5 mg enkrat na dan, daje se ga po operaciji s subkutano injekcijo.
The recommended dose of fondaparinux is 2.5 mg once daily.
Priporočeni odmerek fondaparinuksa je 2,5 mg enkrat na dan.
The recommended dose of fondaparinux is 7.5 mg (patients with body weight  50,  100kg) once daily administered by subcutaneous injection.
Priporočeni odmerek fondaparinuksa je 7,5 mg (bolniki s telesno maso ≥ 50, ≤ 100 kg) enkrat na dan, apliciran s subkutano injekcijo.
The recommended dose of fondaparinux is 7.5 mg (patients with body weight  50,  100kg) once daily administered by subcutaneous injection.
Priporočeni odmerek fondaparinuksa je 7,5 mg (bolniki s telesno maso  50,  100 kg) enkrat na dan, apliciran s subkutano injekcijo.
The recommended dose of FORSTEO is 20 micrograms administered once daily.
Priporočeni odmerek zdravila FORSTEO je 20 mikrogramov enkrat dnevno.
The recommended dose of Gazyvaro in combination with bendamustine is 1,000 mg administered on Day 1 of each 28 day treatment cycle.
Priporočeni odmerek zdravila Gazyvaro v kombinaciji z bendamustinom je 1000 mg 1. dan vsakega 28-dnevnega ciklusa zdravljenja.
The recommended dose of Gazyvaro in combination with bendamustine is shown in Table 4.
Za bolnike s FL je priporočeni odmerek zdravila Gazyvaro v kombinaciji z bendamustinom prikazan v preglednici 4.
The recommended dose of Gazyvaro in combination with chlorambucil is 1,000 mg administered on Day 1 of each cycle.
Priporočeni odmerek zdravila Gazyvaro v kombinaciji s klorambucilom je 1000 mg, uporabljen 1. dan vsakega ciklusa.
The recommended dose of Gazyvaro in combination with chlorambucil is 1,000 mg administered over Day 1 and Day 2 (or Day 1 continued), and on Day 8 and Day 15 of the first 28 day treatment cycle.
Priporočeni odmerek zdravila Gazyvaro v kombinaciji s klorambucilom je 1000 mg, ki ga dajemo 1. in 2. dan (ali v nadaljevanju 1. dne), ter 8. in 15. dan prvega 28-dnevnega ciklusa zdravljenja.
The recommended dose of Gazyvaro in combination with chlorambucil is 1,000 mg administered over Day 1 and Day 2, (or Day 1 continued), and on Day 8 and Day 15 of the first 28 day treatment cycle.
Priporočeni odmerek zdravila Gazyvaro v kombinaciji s klorambucilom je 1000 mg, ki ga dajemo na in 2. dan (ali v nadaljevanju 1. dne) ter 8. in 15. dan prvega 28-dnevnega ciklusa zdravljenja.
The recommended dose of Gilenya is one 0.5 mg capsule taken orally once daily.
Priporočeni odmerek zdravila Gilenya je ena 0,5-miligramska kapsula, ki jo bolnik vzame peroralno enkrat na dan.
The recommended dose of Glivec is 100 mg/day for adult patients with HES/CEL.
Priporočeni odmerek zdravila Glivec pri odraslih bolnikih s HES/CEL je 100 mg/dan.
The recommended dose of Glivec is 400 mg/day for adult patients with MDS/MPD.
Priporočeni odmerek zdravila Glivec pri odraslih bolnikih z MDS/MPD je 400 mg/dan.
The recommended dose of Glivec is 600 mg/day for adult patients with Ph+ ALL.
Priporočeni odmerek zdravila Glivec pri odrasle bolnikih s Ph+ ALL je 600 mg/dan.
The recommended dose of Glivec is 800 mg/day for adult patients with DFSP.
Priporočeni odmerek zdravila Glivec pri odraslih bolnikih s DFSP je 800 mg/dan.
The recommended dose of Glubrava is 30 mg/day pioglitazone plus 1700 mg/day of metformin hydrochloride (this dose is achievable with one tablet of Glubrava 15 mg/850 mg, taken twice a day).
Priporočeni odmerek zdravila Glubrava je 30 mg/dan pioglitazona in 1.700 mg/dan metforminijevega klorida (dan v obliki ene tablete zdravila Glubrava 15 mg/850 mg dvakrat na dan).
The recommended dose of Grastofil for PBPC mobilisation after myelosuppressive chemotherapy is
Priporočeni odmerek Grastofila za izplavljanje PBPC po mielosupresivni kemoterapiji je 0,5 M e./kg/dan (5 mikrogramov/kg/dan).
The recommended dose of Harvoni is one tablet once daily with or without food (see section 5.2).
Priporočeni odmerek zdravila Harvoni je ena tableta enkrat na dan s hrano ali brez nje (glejte poglavje 5.2).
The recommended dose of heparin is 5000 I.U. given as a bolus injection prior to reteplase therapy followed by an infusion of 1000 I.U. per hour starting after the second reteplase bolus.
Priporočeni odmerek heparina je 5000 i.e., dan kot bolusna injekcija pred zdravljenjem z reteplazo, ki mu sledi infuzija 1000 i.e. na uro, ki začne teči po drugem bolusu reteplaze.
The recommended dose of heparin is 5000 I.U. given as a single injection before Rapilysin, followed by an infusion of 1000 I.U. per hour starting after the second Rapilysin injection.
Priporočeni odmerek heparina je 5000 i.e., dan kot enkratna injekcija pred zdravilom Rapilysin, ki mu sledi infuzija 1000 i.e. na uro, ki začne teči po drugem injiciranju zdravila Rapilysin.
The recommended dose of Humira for patients aged 4 to 17 years with plaque psoriasis depends on the weight of your child.
Priporočeni odmerek zdravila Humira za bolnike, stare od 4 do 17 let, z luskavico v plakih je odvisen od telesne mase vašega otroka.
The recommended dose of Humira for patients with ankylosing spondylitis axial spondyloarthritis without radiographic evidence of AS and for patients with psoriatic arthritis is 40 mg adalimumab administered every other week as a single dose via subcutaneous injection.
Priporočeni odmerek zdravila Humira pri bolnikih z ankilozirajočim spondilitisom, aksialnim spondiloartritisom brez radiografskega dokaza za AS in pri bolnikih s psoriatičnim artritisom je 40 mg adalimumaba, apliciran v enkratni subkutani injekciji vsak drugi teden.
The recommended dose of Humira for patients with enthesitis-related arthritis 6 years of age and older is 24 mg/m² body surface area up to a maximum single dose of 40 mg adalimumab administered every other week via subcutaneous injection.
Priporočeni odmerek zdravila Humira pri bolnikih z artritisom, povezanim z entezitison, starih 6 let in več je 24 mg/m² telesne površine do največjega posamičnega odmerka 40 mg adalimumaba vsak drugi teden v subkutani injekciji.
The recommended dose of Humira for patients with enthesitis-related arthritis 6 years of age and older is 24 mg/m² body surface area up to a maximum single dose of 40 mg adalimumab administered every other week via subcutaneous injection.
Priporočeni odmerek zdravila Humira pri bolnikih z artritisom, povezanim z entezitison, starih 6 let in več, je 24 mg/m² telesne površine do največjega posamičnega odmerka 40 mg adalimumaba vsak drugi teden v subkutani injekciji.
The recommended dose of Humira for patients with enthesitis-related arthritis, aged 6 to 17 years depends on the height and weight of the child.
Priporočeni odmerek zdravila Humira za bolnike z artritisom, povezanim z entezitisom, stare od 6 do 17 let, je odvisen od višine in telesne mase otroka.
The recommended dose of Humira for patients with polyarticular juvenile idiopathic arthritis, aged 13 to 17 years, is 40 mg every other week.
Priporočeni odmerek zdravila Humira za bolnike s poliartikularnim juvenilnim idiopatskim artritisom, stare 13 do 17 let, je 40 mg vsak drugi teden.
The recommended dose of Humira for patients with polyarticular juvenile idiopathic arthritis, aged 13 to 17 years, is 40 mg every other week.
Priporočeni odmerek zdravila Humira za bolnike s poliartikularnim juvenilnim idiopatskim artritisom, stare od 13 do 17 let, je 40 mg vsak drugi teden.
The recommended dose of Humira for patients with polyarticular juvenile idiopathic arthritis, aged 13 to 17 years, is 40mg every other week.
Priporočeni odmerek zdravila Humira za bolnike s poliartikularnim juvenilnim idiopatskim artritisom, stare 13 do 17 let, je 40 mg vsak drugi teden.
The recommended dose of Humira for patients with polyarticular juvenile idiopathic arthritis, aged 2 - 12 years, is 24 mg/m² body surface area up to a maximum single dose of 20 mg adalimumab (for patients aged 2 - < 4) and up to a maximum single dose of 40 mg adalimumab (for patients aged 4-12) administered every other week via subcutaneous injection.
Priporočeni odmerek zdravila Humira za bolnike s poliartikularnim juvenilnim idiopatskim artritisom, stare 2 do 12 let, je 24 mg/m2 telesne površine do največjega enkratnega odmerka 20 mg adalimumaba (za bolnike, stare 2 do < 4 leta) in do največjega enkratnega odmerka 40 mg adalimumaba (za bolnike, stare 4 – 12 let), vsak drugi teden v subkutani injekciji.
The recommended dose of Humira for patients with polyarticular juvenile idiopathic arthritis, aged 2 - 12 years, is 24 mg/m² body surface area up to a maximum single dose of 20 mg adalimumab (for patients aged 2-<4) and up to a maximum single dose of 40 mg adalimumab (for patients aged 4-12) administered every other week via subcutaneous injection.
Priporočeni odmerek zdravila Humira za bolnike s poliartikularnim juvenilnim idiopatskim artritisom, stare 2 do 12 let, je 24 mg/m2 telesne površine do največjega enkratnega odmerka 20 mg adalimumaba (za bolnike, stare 2 do < 4 leta) in do največjega enkratnega odmerka 40 mg adalimumaba (za bolnike, stare 4 – 12 let), vsak drugi teden v subkutani injekciji.
The recommended dose of Humira for patients with polyarticular juvenile idiopathic arthritis, aged 2 - 12 years, is 24 mg/m² body surface area up to a maximum single dose of 20 mg adalimumab (for patients aged 2-<4) and up to a maximum single dose of 40 mg adalimumab (for patients aged 4-12) administered every other week via subcutaneous injection.
Priporočeni odmerek zdravila Humira za bolnike s poliartikularnim juvenilnim idiopatskim artritisom, stare 2 do 12 let, je 24 mg/m2 telesne površine do največjega posamičnega odmerka 20 mg adalimumaba (za bolnike, stare 2 do < 4 leta) in do največjega posamičnega odmerka
The recommended dose of Humira for patients with polyarticular juvenile idiopathic arthritis, aged 2 to 12 years depends on the height and weight of the child.
Priporočeni odmerek zdravila Humira za bolnike s poliartikularnim juvenilnim idiopatskim artritisom, stare 2 do 12 let, je odmerek odvisen od telesne mase in višine vašega otroka.
The recommended dose of Humira for patients with polyarticular juvenile idiopathic arthritis, aged 2 to 12 years depends on the height and weight of the child.
Priporočeni odmerek zdravila Humira za bolnike s poliartikularnim juvenilnim idiopatskim artritisom, stare 2 do 12 let, je odvisen od telesne mase in višine vašega otroka.
The recommended dose of Humira for patients with polyarticular juvenile idiopathic arthritis, aged 2 to 12 years depends on the height and weight of the child.
Priporočeni odmerek zdravila Humira za bolnike s poliartikularnim juvenilnim idiopatskim artritisom, stare 2-12 let, je odvisen od telesne mase in višine vašega otroka.
The recommended dose of Humira for patients with polyarticular juvenile idiopathic arthritis, aged 2 to 12 years depends on the height and weight of your child.
Priporočeni odmerek zdravila Humira za bolnike s poliartikularnim juvenilnim idiopatskim artritisom, stare 2 do 12 let, je odvisen od telesne mase in višine vašega otroka.
The recommended dose of HYCAMTIN capsules is 2.3 mg/m2 body surface area/day administered for five consecutive days with a three week interval between the start of each course.
Priporočeni odmerek kapsul HYCAMTIN je 2,3 mg/m2 telesne površine na dan pet dni zapored in s tritedenskimi presledki med začetki vsakega cikla zdravljenja.
The recommended dose of HYCAMTIN capsules is 2.3 mg/m2 body surface area/day administered for five consecutive days with a three week interval between the start of each course.
Priporočeni odmerek kapsul HYCAMTIN je 2,3 mg/m2 telesne površine na dan pet dni zapored in s tritedenskimi presledki med začetki vsakega ciklusa zdravljenja.
The recommended dose of ibandronic acid is 3 mg, administered as an intravenous injection over 15 - 30 seconds, every three months.
Priporočeni odmerek ibandronske kisline je 3 mg v obliki intravenske injekcije, ki jo dajemo 15 do 30 sekund, vsake 3 mesece.
The recommended dose of Ifirmacombi 150 mg/12.5 mg is one tablet a day.
Priporočeni odmerek zdravila Ifirmacombi 150 mg/12,5 mg je ena tableta na dan.
The recommended dose of Ifirmacombi 300 mg/25 mg is one tablet a day.
Priporočeni odmerek zdravila Ifirmacombi 300 mg/25 mg je ena tableta na dan.
The recommended dose of Ilaris for adult patients with gouty arthritis is 150 mg administered subcutaneously as a single dose during an attack.
Priporočeni odmerek zdravila Ilaris za odrasle bolnike z uričnim artritisom je 150 mg, ki ga prejmejo subkutano kot enkraten odmerek v času napada.
The recommended dose of Ilaris for patients with Still’s disease (AOSD and SJIA) with body weight
Priporočeni odmerek zdravila Ilaris za bolnike s Stillovo boleznijo (AOSD ali SJIA) s telesno maso
The recommended dose of Imatinib Accord is 100 mg/day for patients with HES/CEL.
Priporočeni odmerek zdravila Imatinib Accord pri bolnikih s HES/CEL je 100 mg/dan.
The recommended dose of Imatinib Accord is 400 mg/day for patients with MDS/MPD.
Priporočeni odmerek zdravila Imatinib Accord pri bolnikih z MDS/MPD je 400 mg/dan.
The recommended dose of imatinib is 100 mg/day for adult patients with HES/CEL.
Priporočeni odmerek zdravila Imatinib Actavis pri odraslih bolnikih s HES/CEL je 100 mg/dan.
The recommended dose of imatinib is 400 mg/day for adult patients with MDS/MPD.
Priporočeni odmerek imatiniba pri odraslih bolnikih z MDS/MPD je 400 mg/dan.
The recommended dose of imatinib is 400 mg/day for adult patients with MDS/MPD.
Priporočeni odmerek zdravila Imatinib Actavis pri odraslih bolnikih z MDS/MPD je 400 mg/dan.
The recommended dose of Imatinib is 600 mg/day for patients with Ph+ ALL.
Priporočeni odmerek zdravila Imatinib pri bolnikih s Ph+ ALL je 600 mg/dan.
The recommended dose of imatinib is 800 mg/day for adult patients with DFSP.
Priporočeni odmerek zdravila Imatinib Actavis pri odraslih bolnikih s DFSP je 800 mg/dan.
The recommended dose of imatinib is 800 mg/day for patients with DFSP.
Priporočeni odmerek imatiniba pri bolnikih s DFSP je 800 mg/dan.
The recommended dose of imatinib is 800 mg/day for patients with DFSP.
Priporočeni odmerek imatiniba pri bolnikih z DFSP je 800 mg/dan.
The recommended dose of Imatinib is800 mg/day for patients with DFSP.
Priporočeni odmerek zdravila Imatinib pri bolnikih z DFSP je 800 mg/dan.
The recommended dose of Imatinib Teva is 100 mg/day for adult patients with HES/CEL.
Priporočeni odmerek zdravila Imatinib Teva pri odraslih bolnikih s HES/CEL je 100 mg/dan.
The recommended dose of Imatinib Teva is 400 mg/day for adult patients with MDS/MPD.
Priporočeni odmerek zdravila Imatinib Teva pri odraslih bolnikih z MDS/MPD je 400 mg/dan.
The recommended dose of Imatinib Teva is 800 mg/day for adult patients with DFSP.
Priporočeni odmerek zdravila Imatinib Teva pri odraslih bolnikih s DFSP je 800 mg/dan.
The recommended dose of Imatinib Teva is 800 mg/day for adult patients with DFSP.
Priporočeni odmerek zdravila Imatinib Teva pri odraslih bolnikih z DFSP je 800 mg/dan.
The recommended dose of IMBRUVICA is three capsules (420 mg) once a day.
Priporočeni odmerek zdravila IMBRUVICA je tri kapsule (420 mg) enkrat na dan.
The recommended dose of Imnovid is 4 mg per day.
Priporočeni odmerek zdravila Imnovid je 4 mg enkrat na dan.
The recommended dose of Imprida HCT is one tablet per day, to be taken preferably in the morning.
Priporočeni odmerek zdravila Imprida HCT je ena tableta na dan, ki jo je najbolje vzeti zjutraj.
The recommended dose of indinavir is 800 mg orally every 8 hours.
Priporočeni odmerek indinavirja je 800 mg peroralno vsakih 8 ur.
The recommended dose of INTELENCE for adults is 200 mg (one 200 mg tablet) taken orally twice daily (b.i.d.), following a meal (see section 5.2).
Pri odraslih je priporočeni odmerek zdravila INTELENCE 200 mg (ena 200 mg tableta) peroralno dvakrat na dan (b.i.d.), po jedi (glejte poglavje 5.2).
The recommended dose of INTELENCE for adults is 200 mg (two 100 mg tablets) taken orally twice daily (b.i.d.), following a meal (see section 5.2).
Pri odraslih je priporočeni odmerek zdravila INTELENCE 200 mg (dve 100 mg tableti) peroralno dvakrat na dan (b.i.d.), po jedi (glejte poglavje 5.2).
The recommended dose of INTELENCE for paediatric patients (6 years to less than 18 years of age and weighing at least 16 kg) is based on body weight (see table below).
Priporočeni odmerek zdravila INTELENCE pri pediatričnih bolnikih (od 6 let do manj kot 18 let in s telesno maso najmanj 16 kg) temelji na telesni masi (glejte spodnjo preglednico).
The recommended dose of INTELENCE is two tablets twice a day.
Priporočeni odmerek zdravila INTELENCE je dve tableti dvakrat na dan.
The recommended dose of IntronA is 4 to 5 million IU/m2 administered daily subcutaneously.
Priporočeni odmerek zdravila IntronA je 4 do 5 milijonov i.e./m2 dnevno in se injicira subkutano.
The recommended dose of INVANZ for adults and adolescents 13 years of age and older is 1 gram (g) given once a day.
Priporočeni odmerek zdravila INVANZ za odrasle in mladostnike, stare 13 let ali več, je 1 gram (g) enkrat na dan.
The recommended dose of Invirase is 1000 mg (5 x 200 mg capsules) two times daily with ritonavir 100 mg two times daily in combination with other antiretroviral agents.
Priporočeni odmerek zdravila Invirase je 1000 mg (5 x 200 mg kapsul) dvakrat na dan s 100 mg ritonavirja dvakrat na dan v kombinaciji z drugimi protiretrovirusnimi učinkovinami.
The recommended dose of IVEMEND is 150 mg fosaprepitant on Day 1 (day of chemotherapy).
Priporočeni odmerek zdravila IVEMEND je 150 mg fosaprepitanta 1. dan (dan kemoterapije).
The recommended dose of Kalydeco tablets is 150 mg taken orally every 12 hours (300 mg total daily dose) with fat-containing food.
Priporočeni odmerek tablet Kalydeco je 150 mg peroralno vsakih 12 ur (skupni dnevni odmerek 300 mg) z obrokom mastne hrane.
The recommended dose of Ketek is 800 mg (two tablets) once a day.
Priporočeni odmerek zdravila Ketek je 800 mg (dve tableti) enkrat na dan.
The recommended dose of KEYTRUDA is 2 mg/kg administered intravenously over 30 minutes every 3 weeks.
Priporočeni odmerek zdravila KEYTRUDA je 2 mg/kg, uporabljen intravensko v 30 minutah vsake 3 tedne.
The recommended dose of Kineret for rheumatoid arthritis is 100 mg once a day, given by injection under the skin at around the same time each day.
Priporočeni odmerek zdravila Kineret pri revmatoidnem artritisu je 100 mg enkrat na dan, ki se ga vsak dan ob približno istem času injicira v podkožje.
The recommended dose of Kinzalkomb is one tablet a day.
Priporočeni odmerek zdravila Kinzalkomb je ena tableta na dan.
The recommended dose of Kinzalmono is one tablet a day.
Priporočeni odmerek zdravila Kinzalmono je ena tableta na dan.
The recommended dose of Kivexa for adults, adolescents and children weighing 25 kg or more is one tablet once a day.
Priporočeni odmerek zdravila Kivexa za odrasle, mladostnike in otroke, ki tehtajo 25 kg ali več, je ena tableta na dan.
The recommended dose of lamivudine is 300 mg daily.
Odporúčaná dávka lamivudínu je 300 mg denne.
The recommended dose of Lartruvo is 15 mg per kilogram body weight, given twice over a period of three weeks, on days 1 and 8.
Priporočeni odmerek zdravila Lartruvo je 15 mg na kilogram telesne mase in se daje dvakrat v treh tednih, in sicer 1. in 8. dan.
The recommended dose of LEMTRADA is 12 mg/day administered by intravenous infusion for 2 treatment courses.
Priporočeni odmerek zdravila LEMTRADA je 12 mg/dan in se daje z intravensko infuzijo v 2 ciklih zdravljenja.